MARKET

VRTX

VRTX

Vertex Pharmaceuticals Inc
NASDAQ
520.64
-1.74
-0.33%
Opening 10:33 09/25 EDT
OPEN
522.55
PREV CLOSE
522.38
HIGH
525.19
LOW
518.92
VOLUME
133.87K
TURNOVER
--
52 WEEK HIGH
560.25
52 WEEK LOW
374.17
MARKET CAP
131.96B
P/E (TTM)
30.29
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Scholar Rock Holding (SRRK) and Vertex Pharmaceuticals (VRTX)
TipRanks · 7h ago
Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing
Seeking Alpha · 23h ago
CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
NASDAQ · 1d ago
What Is Drawing Fresh Attention To Vertex Pharmaceuticals (VRTX)?
Simply Wall St · 1d ago
Jefferies Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)
TipRanks · 2d ago
Goldman Sachs Reiterates Buy on Vertex as Inaxaplin Data De-Risk Outlook; $653 Price Target Reaffirmed
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Vertex Pharmaceuticals (VRTX) and Nektar Therapeutics (NKTR)
TipRanks · 2d ago
Analysts Conflicted on These Healthcare Names: Edgewise Therapeutics (EWTX), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)
TipRanks · 2d ago
More
About VRTX
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The Company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, acute pain and acromegaly, and it continues to advance clinical and research programs in these areas. It also has a clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including IgA nephropathy, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, congenital adrenal hyperplasia, ACTH-dependent Cushing's syndrome, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1. The Company's pipeline also includes PALSONIFY (paltusotine) and atumelnant. PALSONIFY is the once-daily oral therapy for acromegaly.

Webull offers Vertex Pharmaceuticals Inc stock information, including NASDAQ: VRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRTX stock methods without spending real money on the virtual paper trading platform.